Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart failure device under the microscope: 5,500-Patient registry launches

NCT ID NCT07112924

Disease control Sponsor: Impulse Dynamics Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is a large registry that will follow 5,500 people with heart failure who receive a CCM device, which sends mild electrical signals to the heart to help it pump better. Researchers want to see if the therapy reduces hospital stays and heart-related emergencies over time, and whether it is safe in routine care. Participants are already getting the device as part of their normal treatment, and the study simply collects their health data for up to 5 years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 5,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Aug 2036

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients who will receive/have received CCM therapy with an Impulse Dynamics system

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who have /will be implanted with Impulse Dynamics CCM technologies (e.g. CCM or CCM-D when available) as determined by investigators * Willing and able to provide informed consent, including for use of data for research purposes (e.g. publication, sub-studies/sub-analyses) Exclusion Criteria: * Noncompliant patients (e.g. for follow-up visits, medication, etc.) as determined by investigators. * Subjects with a mechanical tricuspid valve

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart failure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart failure

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    28 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AdventHealth Orlando

    NOT_YET_RECRUITING

    Orlando, Florida, 32803, United States

  • AdventHealth Tampa

    NOT_YET_RECRUITING

    Tampa, Florida, 33613, United States

  • Advocate Aurora Health-St. Lukes

    NOT_YET_RECRUITING

    Milwaukee, Wisconsin, 53215, United States

  • CHRISTUS Trinity Mother Frances Health System

    NOT_YET_RECRUITING

    Tyler, Texas, 75701, United States

  • Cardiovascular Associates of Mesa

    RECRUITING

    Mesa, Arizona, 85206, United States

  • Cardiovascular Specialists of New England Research Foundation

    NOT_YET_RECRUITING

    Londonderry, New Hampshire, 03053, United States

  • Centra Health, Inc. dba Stroobants Cardiovascular Center

    RECRUITING

    Lynchburg, Virginia, 24501, United States

  • David Turbay, MD

    RECRUITING

    El Paso, Texas, 79905, United States

  • Deborah Heart and Lung Center

    NOT_YET_RECRUITING

    Browns Mills, New Jersey, 08015, United States

  • Hackensack University Medical Center

    NOT_YET_RECRUITING

    Hackensack, New Jersey, 07601, United States

  • Henry Ford Providence Hospital

    NOT_YET_RECRUITING

    Novi, Michigan, 48374, United States

  • HonorHealth Research Institute

    NOT_YET_RECRUITING

    Phoenix, Arizona, 85020, United States

  • Legacy Medical Group Cardiology

    NOT_YET_RECRUITING

    Portland, Oregon, 98686, United States

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02144, United States

  • Minneapolis Heart Institute Research Foundation

    NOT_YET_RECRUITING

    Minneapolis, Minnesota, 55407, United States

  • PeaceHealth Southwest Medical Center

    NOT_YET_RECRUITING

    Vancouver, Washington, 98644, United States

  • Peak Heart and Vascular

    RECRUITING

    Surprise, Arizona, 85378, United States

  • Providence St. Vincent Medical Center

    NOT_YET_RECRUITING

    Portland, Oregon, 97225, United States

  • Reading Hospital

    NOT_YET_RECRUITING

    West Reading, Pennsylvania, 19611, United States

  • Rutgers New Jersey Medical School & University Hospital

    NOT_YET_RECRUITING

    Newark, New Jersey, 07103, United States

  • Saint Luke's Hospital Mid America Heart Institute

    NOT_YET_RECRUITING

    Kansas City, Missouri, 64111, United States

  • Saint Luke's Hospital of Kansas City

    NOT_YET_RECRUITING

    Kansas City, Missouri, 64111, United States

  • Texan Cardiovascular Institute

    NOT_YET_RECRUITING

    El Paso, Texas, 79936, United States

  • The Stern Cardiovascular Foundation, Inc

    RECRUITING

    Germantown, Tennessee, 38138, United States

  • Trinity Ann Arbor d/b/a Michigan Heart Ann Arbor

    NOT_YET_RECRUITING

    Ypsilanti, Michigan, 48197, United States

  • University of Arizona and Banner University Medical Center Phoenix

    NOT_YET_RECRUITING

    Phoenix, Arizona, 85006, United States

  • University of Kansas Medical Center

    NOT_YET_RECRUITING

    Kansas City, Kansas, 66160, United States

  • University of Michigan

    NOT_YET_RECRUITING

    Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.